Optimizing Reimbursement Models with Real-World Evidence
The integration of Real-World Evidence (RWE) into healthcare decision-making is transforming how pharmaceutical companies approach Health Economics and Outcomes Research (HEOR), pricing, and reimbursement strategies. To delve into these advancements, the EVIDENCE 360: Real World Evidence, Pricing & Reimbursement Summit Europe is scheduled for 26th-27th May 2025 in Frankfurt, Germany.
Summit Overview
This two-day event is tailored for healthcare professionals, pharmaceutical leaders, policymakers, and researchers. It aims to explore the latest trends, challenges, an
Like
Comment
Share
